Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001780662-26-000002

Chief Financial Officer sold 2,145 shares at $18.46 ($39,597)

  • Chief Financial Officer acquired 2,145 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

PISKEL KYLE · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-04 Exercise or conversion : show line 1 in the form 10b5-1 +2,145 $12.14 $26,040 218,782 D
2026-02-04 Sale : show line 2 in the form 10b5-1 −2,145 $18.46 $39,597 216,637 D
Open-market sales · 2,145 sh · avg $18.46 · $39,597

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-04 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −2,145 2,146 D
Loading xslF345X05/primary_doc.xml…